Anthony Digiandomenico insider trades
Open-market stock purchases and sales by Anthony Digiandomenico, Director, 10% Owner at Exozymes Inc, from SEC Form 4 filings since Apr 9, 2012.
Track record: 13% of 31 scored buys are up 5% or more since purchase, averaging -26%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 1, 2026 | EXOZ Exozymes Inc | Bought (not open market) | — |
| Sep 30, 2026 | CLIR ClearSign Technologies Corp | Bought (not open market) | — |
| Jun 30, 2026 | CLIR ClearSign Technologies Corp | Bought (not open market) | — |
| Mar 31, 2026 | CLIR ClearSign Technologies Corp | Bought (not open market) | — |
| Jan 21, 2026 | NDRA ENDRA Life Sciences Inc | Bought (not open market) | — |
Companies traded
- EXOZ Exozymes Inc: other filings, last Oct 1, 2026
- CLIR ClearSign Technologies Corp: other filings, last Sep 30, 2026
- NDRA ENDRA Life Sciences Inc: 5 buys, last Jan 21, 2026
- MDBH MDB Capital Holdings, LLC: 27 buys, last Apr 28, 2025
- MDBH? MDB Capital Holdings, LLC: 1 buy, last Apr 7, 2025
- PRVB Provention Bio, Inc: 17 buys, last Dec 3, 2019
- CUE Cue Biopharma, Inc: 5 buys, last Jan 2, 2019
- BAZI.OB Bazi International, Inc: other filings, last Aug 27, 2012
Get free alerts when Anthony Digiandomenico files a new trade →